FHTX vs SRPT · rev $22.6M vs rev $1.90B
Foghorn Therapeutics Inc (FHTX) versus Sarepta Therapeutics Inc (SRPT) — a side-by-side from cached financials, not a winner call.
Foghorn Therapeutics Inc (FHTX) is a biotechnology company listed on NASDAQ.
Sarepta Therapeutics Inc (SRPT) is a biotechnology company listed on US.
Latest reported FHTX revenue for 2024-12-31 was $22.6M. Net income was -$86.6M. Revenue was down 33.8% from 2023-12-31 to 2024-12-31. FHTX currently screens at market cap $237.8M.
Latest reported SRPT revenue for 2024-12-31 was $1.90B. Net income was $235.2M. Revenue was up 53.0% from 2023-12-31 to 2024-12-31. SRPT currently screens at market cap $2.34B.
FHTX currently screens at market cap $237.8M. SRPT currently screens at market cap $2.34B.
Not investment advice. Open the FHTX and SRPT stock pages for the full models.
Not investment advice.